FdaApplication
ANDA 062422
Identifiers
- fda_app_no: ANDA062422
Properties
| Property | Value |
|---|---|
| applicant_name | BAXTER HEALTHCARE CORP |
| application_type | ANDA |
| approval_date | 1984-01-31 |
Products (6)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINER | CEPHALOTHIN SODIUM | EQ 40MG BASE/ML | INJECTABLE;INJECTION |
| CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINER | CEPHALOTHIN SODIUM | EQ 20MG BASE/ML | INJECTABLE;INJECTION |
| CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINER | CEPHALOTHIN SODIUM | EQ 40MG BASE/ML | INJECTABLE;INJECTION |
| CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINER | CEPHALOTHIN SODIUM | EQ 20MG BASE/ML | INJECTABLE;INJECTION |
| CEPHALOTHIN SODIUM W/ SODIUM CHLORIDE IN PLASTIC CONTAINER | CEPHALOTHIN SODIUM | EQ 40MG BASE/ML | INJECTABLE;INJECTION |
| CEPHALOTHIN SODIUM W/ SODIUM CHLORIDE IN PLASTIC CONTAINER | CEPHALOTHIN SODIUM | EQ 20MG BASE/ML | INJECTABLE;INJECTION |
6 products